Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mookerjee

Showing results (451-460 of 461) with videos related to

Pageof 47
Sort By:
Frontiers in Immunology|April 4, 2019
Addressing Profiles of Systemic Inflammation Across the Different Clinical Phenotypes of Acutely Decompensated CirrhosisJonel Trebicka, Alex Amoros, Carla Pitarch, et al.
Journal of Hepatology|November 29, 2019
Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLFRichard Moreau, Joan Clària, Ferran Aguilar, et al.
JHEP Reports : Innovation in Hepatology|December 1, 2025
PD-L1 and the risk of bacterial infection in patients with chronic liver diseases: An international multicohort studyAdrià Juanola, Gabriel Mezzano, Elisa Pose, et al.
Journal of Hepatology|June 2, 2023
Randomized, controlled clinical trial of the DIALIVE liver dialysis device versus standard of care in patients with acute-on- chronic liver failureBanwari Agarwal, Rafael Bañares Cañizares, Faouzi Saliba, et al.
Gut|February 14, 2023
Sympathetic nervous activation, mitochondrial dysfunction and outcome in acutely decompensated cirrhosis: the metabolomic prognostic models (CLIF-C MET)Emmanuel Weiss, Carlos de la Peña-Ramirez, Ferran Aguilar, et al.
JAMA|February 5, 2025
Simvastatin and Rifaximin in Decompensated Cirrhosis: A Randomized Clinical TrialElisa Pose, César Jiménez, Giacomo Zaccherini, et al.
Gut|April 15, 2024
Clinical, experimental and pathophysiological effects of Yaq-001: a non-absorbable, gut-restricted adsorbent in models and patients with cirrhosisJinxia Liu, Jane MacNaughtan, Annarein J C Kerbert, et al.
Gut|February 26, 2025
Gene score to quantify systemic inflammation in patients with acutely decompensated cirrhosisJonel Trebicka, Ferran Aguilar, Alberto Queiroz Farias, et al.
Journal of Hepatology|July 17, 2020
The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiologyJonel Trebicka, Javier Fernandez, Maria Papp, et al.
Journal of Hepatology|November 23, 2020
PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosisJonel Trebicka, Javier Fernandez, Maria Papp, et al.
Pageof 47

Showing results (451-460 of 461) with videos related to

Sort By:
Pageof 47
Frontiers in Immunology|April 4, 2019
Addressing Profiles of Systemic Inflammation Across the Different Clinical Phenotypes of Acutely Decompensated CirrhosisJonel Trebicka, Alex Amoros, Carla Pitarch, et al.
Journal of Hepatology|November 29, 2019
Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLFRichard Moreau, Joan Clària, Ferran Aguilar, et al.
JHEP Reports : Innovation in Hepatology|December 1, 2025
PD-L1 and the risk of bacterial infection in patients with chronic liver diseases: An international multicohort studyAdrià Juanola, Gabriel Mezzano, Elisa Pose, et al.
Journal of Hepatology|June 2, 2023
Randomized, controlled clinical trial of the DIALIVE liver dialysis device versus standard of care in patients with acute-on- chronic liver failureBanwari Agarwal, Rafael Bañares Cañizares, Faouzi Saliba, et al.
Gut|February 14, 2023
Sympathetic nervous activation, mitochondrial dysfunction and outcome in acutely decompensated cirrhosis: the metabolomic prognostic models (CLIF-C MET)Emmanuel Weiss, Carlos de la Peña-Ramirez, Ferran Aguilar, et al.
JAMA|February 5, 2025
Simvastatin and Rifaximin in Decompensated Cirrhosis: A Randomized Clinical TrialElisa Pose, César Jiménez, Giacomo Zaccherini, et al.
Gut|April 15, 2024
Clinical, experimental and pathophysiological effects of Yaq-001: a non-absorbable, gut-restricted adsorbent in models and patients with cirrhosisJinxia Liu, Jane MacNaughtan, Annarein J C Kerbert, et al.
Gut|February 26, 2025
Gene score to quantify systemic inflammation in patients with acutely decompensated cirrhosisJonel Trebicka, Ferran Aguilar, Alberto Queiroz Farias, et al.
Journal of Hepatology|July 17, 2020
The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiologyJonel Trebicka, Javier Fernandez, Maria Papp, et al.
Journal of Hepatology|November 23, 2020
PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosisJonel Trebicka, Javier Fernandez, Maria Papp, et al.
Pageof 47